News Release

Promoting the public's understanding of regenerative medicine in society

EuroStemCell and Regenerative Medicine launch an online resource to engage and educate non-experts on the key issues surrounding regenerative medicine

Business Announcement

Future Science Group

EuroStemCell, in partnership with the Future Science Group MEDLINE-indexed journal Regenerative Medicine, have launched a digital platform which provides free-to-access summaries of hot-topic articles from leading international academics published in the journal's recent two-part Special Focus Issue entitled, 'Regenerative Medicine in Society: Interdisciplinary Perspectives'.

The fields of stem cell and regenerative medicine research offer great promise for the production of novel therapeutic techniques in order to enhance patient outcomes. Nevertheless, developments in regenerative medicine have sparked public controversy and there are still numerous social, ethical, regulatory, legal and economic issues that must be addressed. The Special Focus Issue provides an expansive collection of research and perspectives on these important topics.

The double issue was published in collaboration with the European Commission-funded EuroStemCell project through Guest Editors Jan Barfoot and Clare Blackburn (both MRC Centre for Regenerative Medicine, University of Edinburgh, UK), as well as Achim Rosemann (University of Warwick, UK).

Barfoot stated, "Through this collaboration, we have been able to realise this ambitious, global project, attracting leading international scholars and academics to contribute their insights regarding regenerative medicine in society."

The recently launched digital platform accompanies the publication of the two-part Special Focus Issue and presents lay summaries of each article that are freely available to all, which provide key insights into a number of inter-disciplinary research projects from across the globe.

The ultimate aim of the digital gateway is to bridge the gap between researchers and individuals outside of academia. The concise and engaging summaries are targeted to a broader audience to allow maximum involvement.

"Our mission is to stimulate conversations in all sectors on the impact of regenerative medicine on society, so we are very pleased to make summaries of this work freely available," explained Barfoot.

"This body of work provides a rare and in-depth insight into the big questions surrounding the future of the sector. Our hope is that policymakers, regulators, healthcare leaders, funders, patient support organisations and others will read, search and download these research summaries for deliberation with their colleagues."

Adam Price-Evans, Managing Commissioning Editor of Regenerative Medicine stated, "I am delighted that, through partnership with EuroStemCell, we will be able to enhance the outreach of this important work to a wider audience and hopefully educate and spark debate amongst non-experts on important issues surrounding regenerative medicine. Transparency and understanding will continue to be vital going forward, so I hope that this project can contribute to this and assist in realizing the field's great potential."

The EuroStemCell digital gateway with all lay summaries can be accessed here: View Parts I and II of the Special Focus Issue "Regenerative Medicine in Society: Interdisciplinary Perspectives" here:

Part I:

Part II:


About Regenerative Medicine

Regenerative Medicine is part of the internationally recognized Future Medicine portfolio and is supported by a multidisciplinary, international editorial board comprising leading researchers and opinion leaders from academia and industry, including Senior Editor Chris Mason (UCL, UK), and Associate Editors Robert Lanza (Astellas GRM, CA, USA), Phillipe Menasché (Hôpital Européen Georges Pompidou, FR), Gail Naughton (Histogen Inc., CA, USA) and Glyn Stacey (UK Stem Cell Bank, UK).

Regenerative Medicine focuses on the entire spectrum of approaches in regenerative medicine, including small molecule drugs, biologics, biomaterials, tissue engineering, and cell and gene therapies. The peer-reviewed journal uniquely supports this important area of biomedical science and healthcare by publishing the very best research and opinion, encompassing all aspects of the sector ranging from discovery research, to clinical development and commercialization.

For additional information on the journal's aims and scope, editorial board and the latest content, please visit the the Future Medicine website:

The journal is also partnered with RegMedNet, a free eCommunity aiming to promote global collaboration between all members of the regenerative medicine field as well as keep users up to date with the latest news and opinion, by providing exclusive features, webinars and more.

About Future Science Group (FSG)

Founded in 2001, London-based FSG is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. FSG's portfolio includes two imprints, Future Science and Future Medicine. In addition to the core journal publishing business, FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, RegMedNet, Nanomedicine and the award-winning Regenerative Medicine.

The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards. Please see and for more information.

About EuroStemCell

EuroStemCell aims to help European citizens make sense of stem cells by providing independent, expert-reviewed information and road-tested educational resources on stem cells and their impact on society. EuroStemCell received funding from the European Union's Horizon 2020 research and innovation programme (grant agreement number 652796).

EuroStemCell is a partnership of more than 400 stem cell and regenerative medicine labs across Europe, connected via research centres, consortia, networks and hubs. Scientists, clinicians, ethicists, social scientists and science communicators are all part of the project. EuroStemCell also works closely with patients, educators, regulators and policy makers to foster engagement and develop material that meets their needs.

The project team, based in Edinburgh, brings together a range of science communications expertise - from schools engagement and training to resource development, science writing, filmmaking and event management.

EuroStemCell has key partnerships with European Union-funded stem cell research consortia who provide significant contribution to the project financially and scientifically.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.